Pfizer
Kelsey Britton serves as the Senior Director of Cyber Threat Analysis & Response at Pfizer, where responsibilities include leading a global team of over 45 analysts and engineers, managing critical incident response efforts, and developing metrics for briefings to executive leadership. Previously, Kelsey held various roles at Lockheed Martin, including Cyber Intel Analyst Sr, where intrusion attempts were analyzed, and incident response efforts were led. Kelsey's background in cybersecurity includes experience in reverse engineering malware, developing security architectures, and training fellow analysts. Educational credentials include a Master’s degree in Computer and Information Systems Security from Capitol College and a Bachelor’s degree in Information Sciences & Technology from Penn State University.
This person is not in any teams
This person is not in any offices
Pfizer
614 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.